PubMed Health⌕ Search

Biomedical subjects

M R Gondek

Publications and source records attributed to M R Gondek.

6 recordsLinked to original sources
PubMed1997

A thirty-eight year comparison of cancer incidence and mortality among employees at a Connecticut chemical plant.

An important aspect of occupational mortality is the fact that death registration is complete and has good specificity and sensitivity for those cancers with poor survival. However, if available and complete, cancer incidence data are preferable. A unique opportunity presented itself at The Dow Chemical Company's Allyn's Point plant (Gales Ferry, Connecticut) to conduct a cancer incidence and mortality study since the plant began operation in 1951, several years after the establishment of the Connecticut Tumor Registry. All male employees (N = 666) with one or more years of service from 1951-1989 were eligible for the study. Altogether there were 47 primary incident cancers which represented 40 individuals. The Standardized Incidence Ratio (SIR) for all cancer was 124 (95% confidence interval [CI] 91-165). There were 23 deaths reported for all cancers (Standardized Mortality Ratio [SMR] 87, 95% CI 55-131). Only laryngeal cancer incidence was statistically significant (Standardized Incidence Ratio [SIR] 417, 95% CI 135-972). After review of the work history records, this association was found to be inconsistent with a common exposure hazard at the plant.

Adult↗
PubMed1995

Update of the mortality experience of employees with occupational exposure to 1,2-dibromo-3-chloropropane (DBCP).

DBCP (1,2-dibromo-3-chloropropane), a nematocide, was used in the United States from the mid-1950s until 1977. The U.S. Environmental Protection Agency (EPA) restricted and eventually banned its use after the 1977 discovery of DBCP-induced sterility in production workers. The present study is an update of the mortality (1957-1989) experience of a cohort of 548 male employees who had potential for exposure in the production and formulation of DBCP. While adjusting for age, calendar-year, and pay status of all other Midland-area Dow Chemical male employees, there were 68 total observed deaths in the cohort compared to 72.1 expected (Mantel Haenszel Relative Risk 0.9, 95% Confidence Interval 0.7-1.2) and 19 deaths from all malignancies compared to 19.0 expected (RR 1.0, 95% CI 0.6-1.6). Of the a priori anatomic cancer sites of interest, there were no deaths from stomach, liver, kidney, testes, or nasal cavity cancers. Altogether, there were 7 deaths from lung cancer compared to 6.6 expected (RR 1.1, 95% CI 0.5-2.3). Among the 81 employees with exposure categorized as direct for 1 or more years, there were 3 observed lung cancer deaths compared to 0.9 expected (RR 3.3, 95% CI 1.1-9.6). Smoking was a confounding factor in the interpretation of this observation. Although the present analysis nearly doubled the number of person-years from the original study, the conclusions remain limited by the cohort's size and duration of follow-up.

Antinematodal Agents↗
PubMed1991

A 5-year evaluation of a smoking cessation incentive program for chemical employees.

BACKGROUND: This 5-year study of the Dow Chemical Texas Operations 1984-1985 Smoking Cessation Incentive Program (SCIP) evaluated the smoking habits of 1,097 participants and 1,174 nonparticipants. RESULTS: We observed, via questionnaire and saliva cotinine data, that participants were 2.3 times more likely to be long-term (greater than or equal to 5 years) nonusers of tobacco than nonparticipants (10.2% vs 4.4%, P less than or equal to 0.01). However, smoking cessation rates for 3-4 years, 1-2 years, and less than 1 year were similar for participants who remained smokers at the conclusion of SCIP and nonparticipants. Age and the interaction between the management job category and having quit smoking for at least 30 days sometime prior to the worksite program were important predictors of smoking cessation among participants. Thirty-six percent of the participants who were considered exsmokers of 6 months duration at the conclusion of the program in 1985 remained long-term quitters 5 years later. Stress and enjoyment of smoking were the two most important reasons provided by participants for recidivism. CONCLUSIONS: The results of this 5-year evaluation demonstrate the heterogeneity of employee participation and success with a worksite smoking cessation program.

Absenteeism↗
PubMed1988

Use of a population-based tumor registry to estimate cancer incidence among a cohort of chemical workers.

There have been many studies conducted of mortality in occupational cohorts, but few of cancer incidence. Two major facilities of the Western Division of Dow Chemical USA are located fortuitously within an area covered by the population-based California Tumor Registry, which allowed linkage of records to identify incident cancers among 1,403 male workers. Using adjusted county rates for comparison, 49 new cancers were observed in the cohort from 1969 through 1983, whereas 63.0 were expected (standardized incidence ratio = 78, 95% confidence limits = 53 to 103). Nonsignificant excesses were noted for several cancer groups among some categories of workers; however, there was no predominant tumor type within the groups. The successful completion of this collaborative project suggests that using population-based tumor registries for surveillance of occupational cohorts is feasible.

Adult↗
PubMed1978

Medical evaluation of G-sensitive aircrewmen.

Etiologies for loss of consciousness in an aerospace environment are diverse and may present as a perplexing problem in specific cases. The high, sustained G that current aircraft are capable of producing represent another etiology for inflight loss of consciousness. Protective measures give only partial protection, however, and pilots continue to remain susceptible to the excessively high G forces. Certain protective methods, including M-1 and L-1 straining maneuvers, may actually become a source of loss of consciousness if not performed correctly. The current methods utilized to evaluate loss of consciousness in flight, as demonstrated in the specific case of a student pilot performing an improper straining maneuver, are reviewed. Specific measures that might be instituted to prevent certain of these loss-of-consciousness episodes are recommended. The human centrifuge can be an integral part of aeromedical evaluation when G-related problems are involved and is an extremely valuable training device in determining individual G tolerance and enabling controlled G-stress training. Use of the centrifuge in high-G training could well lead to both human life and aircraft cost savings in addition to assuring full utilization of today's high-performance aircraft.

Adult↗